LEVOCARNITIN 1G S INY 5X5ML LGEN CYNATINE FLX incluyendo glioblastoma multiforme y astrocitoma

Description

incluyendo glioblastoma multiforme y astrocitoma anaplásico

SUSTANCIA: MATINEV TAB

Pacientes en hemodiálisis o diálisis peritoneal

DOSIS: 100/50 MG7MG

PRINCIPIO ACTIVO: CIPROFLOXACINO

LEVOCARNITIN 1G S INY 5X5ML LGEN CYNATINE FLX incluyendo glioblastoma multiforme y astrocitomaPRINCIPIO ACTIVO: LEVOCARNITINA

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy